Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03024840Unknown
Randomised trial in liver disease and biliary atresia comparing Sevoflurane Group with Propofol Group (2 arms). Primary endpoints: S-100 beta protein, Neurospecific enolase and 2 more. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03024840.